| 000 | 01742 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515065619.0 | ||
| 264 | 0 | _c20070604 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.wnl.0000260974.41514.83 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKing, W M | |
| 245 | 0 | 0 |
_aOrthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. _h[electronic resource] |
| 260 |
_bNeurology _cMay 2007 |
||
| 300 |
_a1607-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Diseases _xchemically induced |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFemur _xdrug effects |
| 650 | 0 | 4 |
_aFractures, Bone _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Duchenne _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Management |
| 650 | 0 | 4 |
_aScoliosis _xetiology |
| 650 | 0 | 4 |
_aSpinal Fractures _xetiology |
| 650 | 0 | 4 |
_aTibia _xdrug effects |
| 650 | 0 | 4 | _aTime |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRuttencutter, R | |
| 700 | 1 | _aNagaraja, H N | |
| 700 | 1 | _aMatkovic, V | |
| 700 | 1 | _aLandoll, J | |
| 700 | 1 | _aHoyle, C | |
| 700 | 1 | _aMendell, J R | |
| 700 | 1 | _aKissel, J T | |
| 773 | 0 |
_tNeurology _gvol. 68 _gno. 19 _gp. 1607-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000260974.41514.83 _zAvailable from publisher's website |
| 999 |
_c17031786 _d17031786 |
||